JULIE GARSIDE: Open Payments
NPI 1164474888 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$705 in 17 payments from 11 companies in 2025. Trend: 2023 $459 · 2024 $477 · 2025 $705
Food & beverage: $705
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 1 | $161 |
| CVRx, Inc. | 1 | $138 |
| HEARTFLOW, INC. | 2 | $138 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| PFIZER INC. | 3 | $57 |
| BridgeBio Pharma, Inc. | 2 | $41 |
| Novo Nordisk Inc | 1 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Amgen Inc. | 1 | $19 |
Products named: SAPIEN 3 Ultra RESILIA, Barostim Neo System, FFRct, WAINUA, Attruby, VYNDAQEL, Wegovy, LEQVIO.
Industry payments across CO — which companies pay providers there.
